Ozempic and Alzheimer’s: Could the Weight Loss Drug Hold the Key to Dementia Prevention?
Here is the content you requested: 12-month neurological and psychiatric outcomes of semaglutide use for… The observation that semaglutide use was associated with lower risks of cognitive deficits and, to some extent, dementia than the DPP4I sitagliptin and the sulphonylurea glipizide, but a similar risk compared to the SGLT2I empagliflozin aligns with a recent network … Read more